| Lymphatic clearance of the brain: perivascular, paravascular and significance for neurodegenerative diseases ENTP Bakker, BJ Bacskai, M Arbel-Ornath, R Aldea, B Bedussi, ... Cellular and molecular neurobiology 36, 181-194, 2016 | 386 | 2016 |
| Cerebrovascular smooth muscle cells as the drivers of intramural periarterial drainage of the brain R Aldea, RO Weller, DM Wilcock, RO Carare, G Richardson Frontiers in aging neuroscience 11, 2019 | 195 | 2019 |
| Clearance of interstitial fluid (ISF) and CSF (CLIC) group—part of Vascular Professional Interest Area (PIA) Cerebrovascular disease and the failure of elimination of Amyloid … RO Carare, R Aldea, N Agarwal, BJ Bacskai, I Bechman, D Boche, G Bu, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 12 (1 …, 2020 | 84 | 2020 |
| Vasomotion drives periarterial drainage of Aβ from the brain RO Carare, R Aldea, D Bulters, A Alzetani, AA Birch, G Richardson, ... Neuron 105 (3), 400-401, 2020 | 22 | 2020 |
| Computer simulations of in vitro morphogenesis A Robu, R Aldea, O Munteanu, M Neagu, L Stoicu-Tivadar, A Neagu Biosystems 109 (3), 430-443, 2012 | 21 | 2012 |
| High resolution T2-prepared MRI enables non-invasive assessment of CSF flow in perivascular spaces of the human brain L Hirschler, R Aldea, L Petitclerc, IA Ronen, PJH de Koning, ... Proceedings of the 27th Annual Meeting of ISMRM, Montreal, Quebec, Canada 746, 2019 | 11 | 2019 |
| In silico exploration of amyloid‐related imaging abnormalities in the gantenerumab open‐label extension trials using a semi‐mechanistic model R Aldea, HP Grimm, R Gieschke, C Hofmann, D Lott, S Bullain, P Delmar, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 8 (1 …, 2022 | 9 | 2022 |
| Clearance of interstitial fluid (ISF) and CSF (CLIC) group‐part of Vascular Professional Interest Area (PIA), updates in 2022‐2023. Cerebrovascular disease and the failure of … L Kelly, C Brown, D Michalik, CA Hawkes, R Aldea, N Agarwal, R Salib, ... Alzheimer's & Dementia 20 (2), 1421-1435, 2024 | 4 | 2024 |
| Modelling cerebral interstitial flows and their failure in Alzheimer's disease R Aldea University of Southampton, 2018 | 2 | 2018 |
| Amyloid-Related Imaging Abnormalities in Clinical Trials of Gantenerumab in Early Alzheimer Disease S Salloway, J Wojtowicz, N Voyle, CA Lane, G Klein, M Lyons, ... JAMA neurology, 2024 | | 2024 |
| In silico predictions of amyloid-related imaging abnormalities R Aldea, HP Grimm, NA Mazer US Patent App. 18/140,583, 2023 | | 2023 |
| Why does ARIA‐E appear bright? A quantitative model linking brain tissue composition and T2 FLAIR hyperintensities: Neuroimaging / evaluating treatments R Aldea, HP Grimm, R Gieschke, C Hofmann, G Klein, B Kunnecke, ... Alzheimer's & Dementia 16, e046115, 2020 | | 2020 |
| A Quantitative Systems Pharmacology Model of Alzheimer’s Disease Pathology and Treatment Modalities V Ramakrishnan, C Friedrich, C Witt, M Pryor, M Dolton, J Atwal, ... American Conference on Pharmacometrics (ACoP), 2020 | | 2020 |